Loading publications…
The last 5 uploaded publications
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Stæhr, Maik J. Grundeken, Yuki Ishibashi, Héctor M. García‐García, Yoshinobu Onuma (2014). A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. The Lancet, 385(9962), pp. 43-54, DOI: 10.1016/s0140-6736(14)61455-0.
Article146 days agoFast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve
Michail I. Papafaklis, Takashi Muramatsu, Yuki Ishibashi, Λάμπρος Λάκκας, Shimpei Nakatani, Christos V. Bourantas, Jürgen Ligthart, Yoshinobu Onuma, Mauro Echavarría‐Pinto, Georgia Tsirka, Anna Kotsia, Dimitrios Nikas, Owen Mogabgab, Robert‐Jan van Geuns, Katerina Κ. Naka, Dimitrios I. Fotiadis, Emmanouil S. Brilakis, Héctor M. García‐García, Javier Escaned, Felix Zijlstra, Lampros K. Michalis, Patrick W. Serruys (2014). Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve. EuroIntervention, 10(5), pp. 574-583, DOI: 10.4244/eijy14m07_01.
Article146 days agoEverolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study
Roberto Diletti, Αντώνιος Καρανάσος, Takashi Muramatsu, Shimpei Nakatani, Nicolas M. Van Mieghem, Y. Onuma, Sjoerd T. Nauta, Yuki Ishibashi, Mattie Lenzen, Jurgen Ligthart, Carl Schultz, E. Regar, Peter P. de Jaegere, Patrick W. Serruys, F. Zijlstra, Robert‐Jan van Geuns (2014). Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. European Heart Journal, 35(12), pp. 777-786, DOI: 10.1093/eurheartj/eht546.
Article146 days agoThe Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
Pannipa Suwannasom, Yohei Sotomi, Yuki Ishibashi, Rafael Cavalcante, Felipe N. Albuquerque, Carlos Macaya, John A. Ormiston, Jonathan Hill, Iréne Lang, Mohaned Egred, Jean Fajadet, Maciej Lesiak, Jan G.P. Tijssen, Joanna J. Wykrzykowska, Robbert J. de Winter, Bernard Chevalier, Patrick W. Serruys, Yoshinobu Onuma (2016). The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 9(12), pp. 1231-1242, DOI: 10.1016/j.jcin.2016.03.027.
Article146 days agoPrasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)
Takashi Muramatsu, Shinichiro Masuda, Nozomi Kotoku, Ken Kozuma, Hideyuki Kawashima, Yuki Ishibashi, Gaku Nakazawa, Kuniaki Takahashi, Takayuki Okamura, Yosuke Miyazaki, Hiroki Tateishi, Masato Nakamura, Norihiro Kogame, Taku Asano, Shimpei Nakatani, Yoshihiro Morino, Yuki Katagiri, Kai Ninomiya, Shigetaka Kageyama, Hiroshi Takahashi, Scot Garg, Shengxian Tu, Kengo Tanabe, Yukio Ozaki, Patrick W. Serruys, Yoshinobu Onuma (2023). Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN). Circulation Journal, 87(6), pp. 857-865, DOI: 10.1253/circj.cj-23-0051.
Article146 days ago